Cargando…

Rationale of receptor-based antivirals against SARS

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149114/
http://dx.doi.org/10.2165/00128413-200313950-00004
_version_ 1783520740362944512
collection PubMed
description
format Online
Article
Text
id pubmed-7149114
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71491142020-04-13 Rationale of receptor-based antivirals against SARS Inpharma Weekly Correspondence Springer International Publishing 2013-02-09 2003 /pmc/articles/PMC7149114/ http://dx.doi.org/10.2165/00128413-200313950-00004 Text en © Adis International Ltd 2003 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Rationale of receptor-based antivirals against SARS
title Rationale of receptor-based antivirals against SARS
title_full Rationale of receptor-based antivirals against SARS
title_fullStr Rationale of receptor-based antivirals against SARS
title_full_unstemmed Rationale of receptor-based antivirals against SARS
title_short Rationale of receptor-based antivirals against SARS
title_sort rationale of receptor-based antivirals against sars
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149114/
http://dx.doi.org/10.2165/00128413-200313950-00004